Invyncible

Pharmacy choice is the strongest reason to shortlist it

Invyncible names Empower, Strive, Center City, Partell, PerfectRx and MFV in its pharmacy network, with contact details. It allows patients to specify a pharmacy or request a prescription copy. It warns that using an outside pharmacy can change pricing, availability and shipping requirements. That is a meaningful advantage for a shopper who wants to know who will dispense the medication.

The network list is a starting point for verification, not proof that every pharmacy can supply every formulation in every state. Ask which pharmacy would fill the specific order. The company identifies itself as a telemedicine platform; the pharmacy fulfills a prescription only after clinical approval.

A program price needs a supply length

The semaglutide category and linked detail page now agree at $149 for the glycine/B12 starter option. The detail page labels that option 0.45 mg weekly with a 2.5 mg vial. A vial quantity is not, on its own, a verified monthly subscription or refill cost.

Tirzepatide/glycine/B12 is clearer: the detail page shows $180 and a starter option labeled as a four-week supply. The separate B3 program shows $318.75 and an eight-week starter option. Those are different formulations and purchase sizes; a lower monthly equivalent does not mean the same order or the same clinical choice.

The FAQ says price can rise with dose, formulation, supply amount or pharmacy. That makes Invyncible a compare-the-order service rather than a flat-price subscription. Do not extrapolate the first vial into a six-month total without the expected refill program.

The cost mark reflects uncertainty about a comparable ongoing monthly amount, not a finding that Invyncible is expensive. Its pharmacy disclosure and formulation range support stronger marks in those areas. A confirmed refill quote would make the price comparison more useful.

Control over refills also means remembering to reorder

Invyncible says refills are not automatic and advises allowing time for provider review and pharmacy processing. It recommends requesting a refill at least a week before the supply runs out. Payment is authorized at checkout and finalized only after physician approval; an unsuccessful prescription request releases the authorization.

This arrangement suits someone who dislikes automatic renewals, but it puts refill timing on the patient. Overnight transit, where required for a refrigerated program, does not eliminate processing time. The FAQ allows up to five to seven business days before shipment.

Availability follows the formulation

The glycine/B12 product pages exclude Arkansas, California, Indiana, Minnesota, Oregon and South Carolina. The B3 tirzepatide page has a different exclusion list: California, Iowa, Massachusetts, Oregon and Wisconsin. A broad company footprint therefore cannot answer whether your chosen program is available.

Invyncible gets a qualified recommendation for control and disclosure. It is less compelling for shoppers who want a single fixed monthly bill. Our assessment is based on public catalog, pharmacy and FAQ pages; it does not claim firsthand treatment experience or verify checkout pricing.